Anthera Pharmaceuticals, Inc.
ANTH · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,874 | -$55,523 | -$35,220 | -$29,604 |
| Dep. & Amort. | $281 | $266 | $285 | $344 |
| Deferred Tax | $0 | $0 | -$3,541 | $445 |
| Stock-Based Comp. | $4,379 | $6,739 | $3,541 | $2,175 |
| Change in WC | -$5,043 | $1,343 | $487 | $39 |
| Other Non-Cash | -$9,643 | -$1,744 | $3,541 | $1,000 |
| Operating Cash Flow | -$36,900 | -$48,919 | -$30,907 | -$25,601 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$766 | -$80 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $10,000 |
| Investing Cash Flow | $0 | -$766 | -$80 | $10,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$18,094 |
| Stock Issued | $18,253 | $6,733 | $75,299 | $10,388 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $40,421 | $0 | $0 |
| Financing Cash Flow | $18,253 | $23,577 | $75,299 | -$7,706 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18,647 | -$26,108 | $44,312 | -$23,307 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,843 | $46,951 | $2,639 | $25,946 |
| End Cash | $2,196 | $20,843 | $46,951 | $2,639 |
| Free Cash Flow | -$36,900 | -$49,685 | -$30,987 | -$25,601 |